Search

Your search for "DRIO" returned the following results.
Filter Results:
InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Preliminary 2022 Operating Results, Eyes Continued Growth of B2B Revenue

February 6, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today released preliminary unaudited revenue results for the fourth quarter and full year 2022 of approximately $6.7 million and $27.5 million, respectively. According to the update, expected fourth quarter revenue shows a consecutive increase relative to the third quarter of 2022 ($6.6 million), […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Names New Senior VP

January 24, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that Matt Alberico has joined the company as a new senior vice president of growth. In his new role, Alberico will leverage his deep sales strategy experience in rapid-growth environments to help guide the company as it capitalizes on rapidly growing opportunities […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on New Research in Published Journal Article

January 9, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has published new research in the peer-reviewed journal, “Applied Sciences,” as part of a special issue featuring digital therapeutics applications for chronic disease management. The research shows improved outcomes for users living with diabetes across different racial and ethnic groups. According to the […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Validates Position as Leading Provider of Integrated Solutions in Employer and Payer Markets

January 3, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a large Northeast U.S. supermarket chain selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023. This marks 100 enterprise contracts signed for DarioHealth and validates its strategic position as a leading […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Delivering, Well-Positioned in ‘High-Demand’ Market

December 22, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it is “adding contracts with self-insured employers and national health plans as Amazon and CVS vie to lead value-based, patient-centric virtual healthcare.” According to the announcement, digital healthcare is delivering both better health outcome and also lower costs for the […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Move Device Reduces Back Pain, Study Shows

December 19, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting the publication of a new study in “Frontiers in Physiology,” a peer-reviewed journal; the study shows the effectiveness DRIO’s musculoskeletal solution, which uses real-time biofeedback and behavior training to reduce back pain. According to the announcement, the study evaluated retrospective data […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Accounts Utilizing Multi-Chronic Solution

December 1, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that two employers selected Dario as part of an offering from a leading benefits brokerage partner. According to the update, the employers will deploy Dario’s solutions to help improve the cardiometabolic and musculoskeletal health of employees beginning in the first quarter […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announce Participation in Upcoming Conferences

November 16, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, will be participating in two conferences scheduled for November: the Craig-Hallum Alpha Select Conference and the BTIG Digital Health Forum. Slated for Nov. 17, 2022, the 13th annual Craig-Hallum Alpha Select event will be held in New York City and features one-on-one meetings with […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 2022 Financial, Corporate Report

November 15, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has reported financial numbers and corporate updates for third quarter 2022. Highlights of the report include revenues of $6.6 million, an increase of 17.3% from the $5.6 million reported in Q3 2021, with B2B revenues growing to 63.5% of total revenue for the quarter, up from […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q3 2022 Results, Conference Call

November 9, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced it would release its financial results for the third quarter ended Sept. 30, 2022, after markets close on Monday, Nov. 14, 2022. The company will host a conference call and webcast at 8:30 am Eastern Time on Tuesday, Nov. 15, 2022, […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Employer Contracts to Provide Full Suite of Digital Health Solutions

October 20, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has inked two new contracts for the company’s full suite of chronic condition management solutions. DRIO solutions were chosen by the two employers to “help improve overall employee health.” Both contracts — one with a global Fortune 1000 company and one […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces 1st Contract with Government Benefits Entity

October 13, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a mid-sized Midwestern city selected Dario to provide its full suite of digital therapeutics solutions to several thousand city employees beginning in the first quarter of 2023. According to the update, the contract is Dario’s first with a government benefits […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes Promising Clinical Research for Its Biofeedback Posture Device

September 22, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced new research at the International Association of the Study of Pain (“IASP”) 2022 World Congress on Pain, being held in person in Toronto, Ontario, and virtually from September 19 – 23, 2022. The research examines the link between the use of […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q2 2022 Financial Report, Corporate Update

August 15, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting on its financial results for the second quarter 2022; the company also released a corporate and commercial update. Highlights of the report include revenue for the quarter, which totaled 6.2 million, a 17.5% increase from Q2 2021, which was $5.3 million, with […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research at Conference Showing Support for Rural Areas

August 12, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has presented results from its recent research showing impact of DRIO solutions to support people living in rural areas by delivering lasting health improvements. According to the presentation, the research focused on Dario’s ability to improve the health of members in rural areas, […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Solution to Drive Digital, Seamless Experience for National Health Plan

August 11, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a national health plan selected its solution to drive self-service across its mental wellbeing care resources. According to the update, Dario’s behavioral health solution will become part of the plan’s platform to increase access to navigation, self-help and coaching. “We […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q2 Earnings Results

August 10, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, will release its financial results for Q2 2022, the period ended June 30, 2022, next week. The report will be issued on Monday, Aug. 15, 2022. In addition, the company has scheduled a conference call and webcast to discuss the report. That call […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Present Research Regarding Digital Solution on Depression, Anxiety at APA Convention

August 4, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is sharing the results of its studies on anxiety and depression at the American Psychological Association (“APA”) annual convention. The three-day convention begins today and runs through Aug. 6, 2022; it is being held virtually and in person in Minneapolis, Minnesota. According to […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Multi-Chronic Contract with National Employer for Full-Solution Suite

July 21, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has inked a new deal to provide its full suite of integrated chronic-condition management solutions to a national employer; this new contract outlines Dario’s commitment to support employees living with diabetes, high blood pressure, and needs related to weight, musculoskeletal pain and behavioral health. The new […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Contract with National Employer

June 21, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider of integrated technology solutions for financial professionals. According to the update, Dario expects to launch the new account in the third quarter of 2022. “Demand for digital […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Solera Health for Added Hypertension Management Solutions

June 16, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is partnering with Solera Health to offer a world-class solution for treating hypertension. Solera Health is a premier platform for connecting people to proven, personalized health solutions, and this new partnership expands Solera’s suite of best-in-class digital and community evidence-based health solutions. The […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with OrbiMed to Close on $50 Million Credit Facility

June 9, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has closed on a senior secured term loan facility of up to $50 million with OrbiMed. According to the announcement, the investment from the elite healthcare fund indicates validation and the company’s access to capital, thereby creating a pathway to execute on DRIO’s strategic operating […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presenting Key Findings from Three New Studies at ADA Scientific Sessions

June 3, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that company officials are presenting three new studies at the American Diabetes Association’s (“ADA”) 82nd Scientific Sessions; the sessions begin today and run through June 7, 2022, in New Orleans. According to the announcement, two of the studies demonstrated noticeable improvement in glucose […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Commercial Contracts as Market Develops Appreciation for Integrated Digital Solutions

May 19, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced two new contracts to provide digital therapeutics solutions to a national employer and a provider, both of which are expected to begin enrolling members in the third quarter of 2022. “Dario continues to build a strong client base across its suite […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Record Quarterly Revenues in Q1 2022

May 12, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today reported financial results for the first quarter 2022 and provided a corporate and commercial update. “Our first quarter results reflect our increasingly successful transition to a B2B model with growing revenue and gross margins,” said Dario’s Chief Executive Officer Erez Raphael. “We […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q1 2022 Results, Conference Call

May 4, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced it would release its financial results for the first quarter ended March 31, 2022, on Thursday, May 12, 2022. On the same day, the company will host a conference call and webcast at 8:30 am Eastern Time. DRIO’s Chief Executive Officer […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research Supporting ‘Digital Solutions That Prioritize a Whole Health Experience’

April 27, 2022

DarioHealth (NASDAQ: DRIO) today announced publication of a retrospective, real-world study demonstrating the impact of managing diabetes and weight together on a single digital platform at the Advanced Technologies and Treatments for Diabetes (“ATTD”) Conference being held April 27-30 in Barcelona and online. “I am proud to share new evidence that Dario’s approach to providing […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Solutions for Health Plan Colorado Access

April 14, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced its entry into a new agreement with Colorado Access, the largest public sector health plan in the state of Colorado. Under the agreement, Dario will provide digital chronic condition management solutions for Colorado Access’ Medicaid population, beginning with thousands of its […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Additional Employer Contracts

March 23, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced two new employer agreements, including one with a U.S.- based social platform employer and another with a global health care company. According to the update, the contracts are expected to launch in the second quarter of 2022. Rick Anderson, president and […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q4, Full-Year 2021 Financial Report, Operational Update

March 22, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has reported its financial numbers and corporate update for the fourth quarter and full year. The company noted that it had experienced a transformational year with strong revenue growth of 190% quarter-over-quarter and 171% full year-over-full year, along with adding 54 new accounts […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q4 and Full Year 2021 Results

March 14, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that it will release its financial results for the fourth quarter and full year ended Dec. 31, 2021, after the close of trading on Monday, March 21, 2022. In addition, the company’s CEO Erez Raphael, president and general manager of North […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Two New Contracts to Growing Number of Clients

March 9, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has signed two new contracts in the employer and provider markets; these new contracts serve as indicators of the company’s success in winning busiess in these sectors. The contracts, which are expected to begin in Q2 2022, will implement Dario’s […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Participate in Upcoming Cowen Healthcare Conference

March 7, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that management will participate in the Cowen 42nd Annual Healthcare Conference, which is slated to take place virtually on March 7-9, 2022. DarioHealth’s CEO Erez Raphael and president and general manager of North America Rick Anderson will participate in a fireside […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Direct Offering Pricing, Inks Agreement with Sanofi US

March 1, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has entered into definitive agreements with institutional investors; those investors include Israel-based insurance companies. The registered direct offering includes the issuance of approximately 5,342,013 shares of DRIO common stock or common stock equivalents at a price of $7.49 per share. The company […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes Learnings from Single DTx Platform Approach to Chronic Condition Management

February 9, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced the publication of a retrospective, real-world study demonstrating the impact of managing blood pressure and diabetes together on the same digital platform. The study, which showed a significant improvement in average blood glucose levels during the first six months of using […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs Four New Employer Contracts, Clients Now Number 40+

February 8, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has entered new contracts agreeing to deliver its digital therapeutics solutions for four employers; the new accounts are slated to being during the first half of 2022. According to the company, its new clients include a northeast regional employer that contracted for Dario’s […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Strategic Move to Acquire Physimax Technologies

January 20, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced its entry into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. A leading provider of computer vision (“CV”) technology for musculoskeletal (“MSK”) functional screening and predictive risk of injury assessment, Physimax’s […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with Leading Regional Health Plan

January 19, 2022

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced that it has entered into an agreement with a larger regional health plan. The agreement calls for DRIO to provide its digital therapeutic solution for diabetes to eligible Medicaid members in and around the mid-Atlantic region. According to the announcement, the contract should […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Host Jan. 19 Investor Webinar on Navigating Emerging Digital Health Trends

January 18, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that it will host an investor webinar on navigating emerging digital health trends in 2022. Interested parties are invited to join DarioHealth’s management and two renowned industry experts at 8 a.m. ET on Wednesday, Jan. 19, to better understand how strong […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures New Contracts in the Employer Market

January 6, 2022

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced two new contracts to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. According to the update, the new clients include two Northeast regional employers, one in the finance industry set to deploy Dario’s full suite of […]

No ResultsNo content matches your search/filter.

 

 

 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).